- Report
- July 2026
- 246 Pages
Global
From €3778EUR$4,150USD£3,251GBP
- Report
- November 2025
- 180 Pages
Global
From €4096EUR$4,500USD£3,525GBP
- Report
- September 2026
- 194 Pages
Global
From €3227EUR$3,545USD£2,777GBP
€3586EUR$3,939USD£3,086GBP
- Report
- February 2026
- 250 Pages
Global
From €4087EUR$4,490USD£3,517GBP
- Report
- September 2026
- 174 Pages
Global
From €5325EUR$5,850USD£4,583GBP
- Report
- November 2025
- 150 Pages
Global
From €3413EUR$3,750USD£2,938GBP
- Report
- July 2026
- 114 Pages
Global
From €4324EUR$4,750USD£3,721GBP
- Report
- July 2026
- 160 Pages
Global
From €3022EUR$3,320USD£2,601GBP
€3778EUR$4,150USD£3,251GBP
- Report
- February 2026
- 453 Pages
Global
From €4506EUR$4,950USD£3,878GBP
- Report
- February 2026
- 445 Pages
Global
From €4506EUR$4,950USD£3,878GBP
- Report
- February 2026
- 469 Pages
Global
From €4506EUR$4,950USD£3,878GBP
- Report
- January 2026
- 260 Pages
Global
From €3288EUR$3,613USD£2,830GBP
€3869EUR$4,250USD£3,329GBP
- Report
- September 2026
- 193 Pages
Global
From €3227EUR$3,545USD£2,777GBP
€3586EUR$3,939USD£3,086GBP
- Report
- September 2026
- 180 Pages
Global
From €3227EUR$3,545USD£2,777GBP
€3586EUR$3,939USD£3,086GBP
- Report
- February 2026
- 250 Pages
Global
From €4087EUR$4,490USD£3,517GBP
- Report
- February 2026
- 250 Pages
Global
From €4087EUR$4,490USD£3,517GBP
- Report
- February 2026
- 250 Pages
Global
From €4087EUR$4,490USD£3,517GBP
- Report
- February 2026
- 250 Pages
Global
From €4087EUR$4,490USD£3,517GBP
- Report
- September 2026
- 184 Pages
Global
From €5325EUR$5,850USD£4,583GBP
- Report
- November 2025
- 150 Pages
Global
From €3413EUR$3,750USD£2,938GBP

The Structural Heart Device market is a subset of the Cardiovascular Devices market, which includes products used to diagnose and treat cardiovascular diseases. Structural Heart Devices are used to treat structural heart defects, such as atrial septal defects, patent foramen ovale, and mitral valve regurgitation. These devices are typically implanted in the heart and can include transcatheter aortic valve replacement (TAVR) devices, occluders, and annuloplasty rings.
Structural Heart Devices are used to improve patient outcomes and reduce the need for open-heart surgery. They are also used to reduce the risk of stroke and other complications associated with structural heart defects.
Some companies in the Structural Heart Device market include Abbott, Boston Scientific, Edwards Lifesciences, Medtronic, and St. Jude Medical. Show Less Read more